FDA Drug Recalls

Recalls / Class II

Class IID-0772-2020

Product

TESTOSTERONE CYP 200MG/ML OIL INJ in 10 mL vial Assurance Infusion (713) 533-8800

Affected lot / code info
Lots: 09122019@9 Exp. 03/10/2020; 09242019@9 Exp. 03/22/2020; 09192019@20 Exp. 03/17/2020; 10032019@8 Exp. 03/31/2020; 10032019@11 Exp. 03/31/2020; 10182019@5 Exp. 04/15/2020; 10242019@7 Exp. 04/21/2020; 10232019@24 Exp. 04/20/2020; 11042019@12 Exp. 05/02/2020; 11212019@3 Exp. 05/19/2020; 11212019@2 Exp. 05/19/2020; 11042019@15 Exp. 05/02/2020

Why it was recalled

Lack of sterility assurance.

Recalling firm

Firm
Assurance Infusion
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2626 S Loop W Ste 555, Houston, Texas 77054-2652

Distribution

Quantity
166 vials
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2019-12-20
FDA classified
2020-01-13
Posted by FDA
2020-01-22
Terminated
2021-10-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0772-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.